119 related articles for article (PubMed ID: 35092711)
1. Bioinspired Lipoproteins of Furoxans-Oxaliplatin Remodel Physical Barriers in Tumor to Potentiate T-Cell Infiltration.
Wang Y; Xie H; Wu Y; Xu S; Li Y; Li J; Xu X; Wang S; Li Y; Zhang Z
Adv Mater; 2022 Apr; 34(14):e2110614. PubMed ID: 35092711
[TBL] [Abstract][Full Text] [Related]
2. Extracellular Matrix-Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity.
Wu Y; Li Y; Hu Z; Li Y; Zhang S; Bao X; Zhou Y; Gao Y; Li Y; Zhang Z
Adv Mater; 2024 Apr; 36(15):e2310982. PubMed ID: 38216153
[TBL] [Abstract][Full Text] [Related]
3. Bioinspired nanovehicle of furoxans-oxaliplatin improves tumoral distribution for chemo-radiotherapy.
Qian X; Wang Y; Xie H; Wang C; Li J; Lei Y; Liu H; Wu Y; Li Y; Zhang Z
J Control Release; 2023 Jan; 353():447-461. PubMed ID: 36470332
[TBL] [Abstract][Full Text] [Related]
4. Bioinspired Lipoproteins of Furoxans-Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance.
Sun M; Xie H; Zhang W; Li X; Jiang Z; Liang Y; Zhao G; Huang N; Mao J; Liu G; Zhang Z
Adv Sci (Weinh); 2024 Feb; 11(6):e2306190. PubMed ID: 38049204
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Membrane-Coated Nano-Gemcitabine Promotes Lymphocyte Infiltration and Synergizes AntiPD-L1 to Restore the Tumoricidal Function.
Li J; Wu Y; Wang J; Xu X; Zhang A; Li Y; Zhang Z
ACS Nano; 2023 Jan; 17(1):322-336. PubMed ID: 36525314
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Activated Size-Enlargeable Bioinspired Lipoproteins Access Cancer Cells in Tumor to Elicit Anti-Tumor Immune Responses.
Li J; Wang H; Wang Y; Gong X; Xu X; Sha X; Zhang A; Zhang Z; Li Y
Adv Mater; 2020 Sep; 32(38):e2002380. PubMed ID: 33252171
[TBL] [Abstract][Full Text] [Related]
7. Nitric Oxide-Loaded Bioinspired Lipoprotein Normalizes Tumor Vessels To Improve Intratumor Delivery and Chemotherapy of Albumin-Bound Paclitaxel Nanoparticles.
Wu Y; Xie H; Li Y; Bao X; Lu GL; Wen J; Gao Y; Li Y; Zhang Z
Nano Lett; 2023 Feb; 23(3):939-947. PubMed ID: 36701555
[TBL] [Abstract][Full Text] [Related]
8. CD8
Farhood B; Najafi M; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
[TBL] [Abstract][Full Text] [Related]
9. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
10. CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination.
Ahrends T; Bąbała N; Xiao Y; Yagita H; van Eenennaam H; Borst J
Cancer Res; 2016 May; 76(10):2921-31. PubMed ID: 27020860
[TBL] [Abstract][Full Text] [Related]
11. Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy.
Elia AR; Grioni M; Basso V; Curnis F; Freschi M; Corti A; Mondino A; Bellone M
Clin Cancer Res; 2018 May; 24(9):2171-2181. PubMed ID: 29490991
[No Abstract] [Full Text] [Related]
12. DLL1 orchestrates CD8
Zhang N; Yin R; Zhou P; Liu X; Fan P; Qian L; Dong L; Zhang C; Zheng X; Deng S; Kuai J; Liu Z; Jiang W; Wang X; Wu D; Huang Y
Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34035167
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
14. [Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].
Benchetrit F; Gazagne A; Adotevi O; Haicheur N; Godard B; Badoual C; Fridman WH; Tartour E
Bull Cancer; 2003; 90(8-9):677-85. PubMed ID: 14609756
[TBL] [Abstract][Full Text] [Related]
15. Tumor perfusion enhancement by ultrasound stimulated microbubbles potentiates PD-L1 blockade of MC38 colon cancer in mice.
Li N; Tang J; Yang J; Zhu B; Wang X; Luo Y; Yang H; Jang F; Zou J; Liu Z; Wang Z
Cancer Lett; 2021 Feb; 498():121-129. PubMed ID: 33129956
[TBL] [Abstract][Full Text] [Related]
16. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
[TBL] [Abstract][Full Text] [Related]
17. Altered CD8+ T-Cell Lymphocyte Function and TC1 Cell Stemness Contribute to Enhanced Malignant Tumor Properties in Murine Models of Sleep Apnea.
Akbarpour M; Khalyfa A; Qiao Z; Gileles-Hillel A; Almendros I; Farré R; Gozal D
Sleep; 2017 Feb; 40(2):. PubMed ID: 28364502
[TBL] [Abstract][Full Text] [Related]
18. Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors.
Huang Y; Chen Y; Zhou S; Chen L; Wang J; Pei Y; Xu M; Feng J; Jiang T; Liang K; Liu S; Song Q; Jiang G; Gu X; Zhang Q; Gao X; Chen J
Nat Commun; 2020 Jan; 11(1):622. PubMed ID: 32001695
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.
Sharma RK; Chheda ZS; Jala VR; Haribabu B
Expert Rev Vaccines; 2015 Apr; 14(4):537-49. PubMed ID: 25482400
[TBL] [Abstract][Full Text] [Related]
20. Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells.
Foy SP; Mandl SJ; dela Cruz T; Cote JJ; Gordon EJ; Trent E; Delcayre A; Breitmeyer J; Franzusoff A; Rountree RB
Cancer Immunol Immunother; 2016 May; 65(5):537-49. PubMed ID: 26961085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
